Metabolic associated fatty liver disease is a risk factor for chronic kidney disease

BACKGROUND AND AIMS: To clarify the relationship between metabolic dysfunction‐associated fatty liver disease (MAFLD) and chronic kidney disease (CKD). METHODS: The participants were divided into four groups by the presence or absence of fatty liver disease (FLD) and metabolic dysfunction (MD). MAFL...

Descripción completa

Detalles Bibliográficos
Autores principales: Hashimoto, Yoshitaka, Hamaguchi, Masahide, Okamura, Takuro, Nakanishi, Naoko, Obora, Akihiro, Kojima, Takao, Fukui, Michiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847128/
https://www.ncbi.nlm.nih.gov/pubmed/34561962
http://dx.doi.org/10.1111/jdi.13678

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847128/
https://www.ncbi.nlm.nih.gov/pubmed/34561962
http://dx.doi.org/10.1111/jdi.13678

Ejemplares similares